Gainers
Chembio Diagnostics (NASDAQ:
CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million.
Lexaria Bioscience (NASDAQ:
LEXX) shares
Gainers
- Chembio Diagnostics (NASDAQ:CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million.
- Lexaria Bioscience (NASDAQ:LEXX) shares rose 45.82% to $9.61. The company's market cap stands at $49.0 million.
- NeuroMetrix (NASDAQ:NURO) stock moved upwards by 31.47% to $13.2. The company's market cap stands at $65.2 million.
- NanoVibronix (NASDAQ:NAOV) shares moved upwards by 11.06% to $0.8. The company's market cap stands at $19.2 million.
- Entasis Therapeutics Hldg (NASDAQ:ETTX) stock rose 8.46% to $2.69. The market value of their outstanding shares is at $127.2 million.
- Acutus Medical (NASDAQ:AFIB) stock increased by 8.33% to $14.56. The market value of their outstanding shares is at $489.5 million.
Losers
- Cerevel Therapeutics Hldg (NASDAQ:CERE) shares fell 19.93% to $18.0 during Wednesday's pre-market session. The company's market cap stands at $2.5 billion.
- Magenta Therapeutics (NASDAQ:MGTA) stock declined by 14.61% to $7.6. The market value of their outstanding shares is at $444.6 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares decreased by 13.86% to $3.42. The market value of their outstanding shares is at $76.2 million.
- Ikena Oncology (NASDAQ:IKNA) stock declined by 7.12% to $12.41. The company's market cap stands at $444.9 million.
- Aytu BioPharma (NASDAQ:AYTU) stock decreased by 4.69% to $4.07. The company's market cap stands at $102.4 million.
- Ardelyx (NASDAQ:ARDX) shares fell 4.48% to $1.92. The company's market cap stands at $189.5 million.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
